Literature DB >> 17274105

In vivo magnetic resonance spectroscopy of transgenic mouse models with altered high-energy phosphoryl transfer metabolism.

W Klaas Jan Renema1, Hermien E Kan, Bé Wieringa, Arend Heerschap.   

Abstract

Studies of transgenic mice provide powerful means to investigate the in vivo biological significance of gene products. Mice with an under- or overexpression of enzymes involved in high-energy phosphoryl transfer (approximately P) are particulary attractive for in vivo MR spectroscopy studies as the substrates of these enzymes are metabolites that are visible in MR spectra. This review provides a brief overview of the strategies used for generation and study of genetically altered mice and introduces the reader to some practical aspects of in vivo MRS studies on mice. The major part of the paper reviews results of in vivo MRS studies on transgenic mice with alterations in the expression of enzymes involved in approximately P metabolism, such as creatine kinase, adenylate kinase and guanidinoacetate methyl transferase. The particular metabolic consequences of these enzyme deficiencies in skeletal muscle, brain, heart and liver are addressed. Additionally, the use of approximately P systems as markers of gene expression by MRS, such as after viral transduction of genes, is described. Finally, a compilation of tissue levels of metabolites in skeletal muscle, heart and brain of wild-type and transgenic mice, as determined by in vivo MRS, is given. During the last decade, transgenic MRS studies have contributed significantly to our understanding of the physiological role of phosphotransfer enzymes, and to the view that these enzymes together build a much larger metabolic energy network that is highly versatile and can dynamically adapt to intrinsic genotoxic and extrinsic physiological challenges. (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17274105     DOI: 10.1002/nbm.1117

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  5 in total

1.  Creatine kinase B is necessary to limit myoblast fusion during myogenesis.

Authors:  Adriana Simionescu-Bankston; Christophe Pichavant; James P Canner; Luciano H Apponi; Yanru Wang; Craig Steeds; John T Olthoff; Joseph J Belanto; James M Ervasti; Grace K Pavlath
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-25       Impact factor: 4.249

2.  Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion.

Authors:  Roddy S O'Connor; Craig M Steeds; Robert W Wiseman; Grace K Pavlath
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

3.  (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.

Authors:  Christian Mirkes; Gunamony Shajan; Grzegorz Chadzynski; Kai Buckenmaier; Benjamin Bender; Klaus Scheffler
Journal:  MAGMA       Date:  2016-01-25       Impact factor: 2.310

4.  Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.

Authors:  Craig A Lygate; Dunja Aksentijevic; Dana Dawson; Michiel ten Hove; Darci Phillips; Joseph P de Bono; Debra J Medway; Liam Sebag-Montefiore; Imre Hunyor; Keith M Channon; Kieran Clarke; Sevasti Zervou; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  Circ Res       Date:  2013-01-16       Impact factor: 17.367

5.  Combining chemical exchange saturation transfer and 1 H magnetic resonance spectroscopy for simultaneous determination of metabolite concentrations and effects of magnetization exchange.

Authors:  Maike Hoefemann; André Döring; Nicole Damara Fichtner; Roland Kreis
Journal:  Magn Reson Med       Date:  2020-11-05       Impact factor: 4.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.